Citigroup’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,541,983
| Closed | -$216M | – | 7966 |
|
|
2019
Q4 | $216M | Buy |
2,541,983
+2,275,369
| +853% | +$152M | 0.16% | 117 |
|
|
2019
Q3 | $13.3M | Buy |
266,614
+124,263
| +87% | +$4.96M | 0.01% | 1192 |
|
|
2019
Q2 | $5.19M | Buy |
142,351
+139,092
| +4,268% | +$4.54M | ﹤0.01% | 1945 |
|
|
2019
Q1 | $92K | Sell |
3,259
-104,343
| -97% | -$2.46M | ﹤0.01% | 5831 |
|
|
2018
Q4 | $2.06M | Buy |
107,602
+54,135
| +101% | +$1.26M | ﹤0.01% | 2636 |
|
|
2018
Q3 | $1.6M | Sell |
53,467
-270,733
| -84% | -$10.2M | ﹤0.01% | 2971 |
|
|
2018
Q2 | $11.9M | Buy |
324,200
+314,534
| +3,254% | +$10.2M | 0.01% | 1156 |
|
|
2018
Q1 | $318K | Buy |
9,666
+7,106
| +278% | +$222K | ﹤0.01% | 4465 |
|
|
2017
Q4 | $70K | Sell |
2,560
-407
| -14% | -$12.5K | ﹤0.01% | 5937 |
|
|
2017
Q3 | $110K | Buy |
2,967
+380
| +15% | +$14K | ﹤0.01% | 5494 |
|
|
2017
Q2 | $98K | Sell |
2,587
-19,792
| -88% | -$881K | ﹤0.01% | 5360 |
|
|
2017
Q1 | $1.09M | Sell |
22,379
-16,114
| -42% | -$735K | ﹤0.01% | 3120 |
|
|
2016
Q4 | $1.31M | Buy |
38,493
+16,059
| +72% | +$570K | ﹤0.01% | 3426 |
|
|
2016
Q3 | $847K | Sell |
22,434
-3,817
| -15% | -$144K | ﹤0.01% | 3405 |
|
|
2016
Q2 | $883K | Sell |
26,251
-28,220
| -52% | -$995K | ﹤0.01% | 3080 |
|
|
2016
Q1 | $1.73M | Buy |
54,471
+49,582
| +1,014% | +$1.62M | ﹤0.01% | 2674 |
|
|
2015
Q4 | $183K | Buy |
4,889
+1,362
| +39% | +$51.5K | ﹤0.01% | 4830 |
|
|
2015
Q3 | $134K | Sell |
3,527
-58,298
| -94% | -$2.05M | ﹤0.01% | 4789 |
|
|
2015
Q2 | $1.77M | Buy |
61,825
+10,772
| +21% | +$300K | ﹤0.01% | 2643 |
|
|
2015
Q1 | $1.43M | Buy |
51,053
+35,610
| +231% | +$1M | ﹤0.01% | 2766 |
|
|
2014
Q4 | $427K | Buy |
15,443
+12,925
| +513% | +$320K | ﹤0.01% | 4027 |
|
|
2014
Q3 | $56K | Sell |
2,518
-3,374
| -57% | -$85.7K | ﹤0.01% | 5238 |
|
|
2014
Q2 | $171K | Buy |
5,892
+1,115
| +23% | +$29.8K | ﹤0.01% | 4262 |
|
|
2014
Q1 | $136K | Sell |
4,777
-21,476
| -82% | -$711K | ﹤0.01% | 4705 |
|
|
2013
Q4 | $1.01M | Buy |
26,253
+14,117
| +116% | +$505K | ﹤0.01% | 3165 |
|
|
2013
Q3 | $406K | Sell |
12,136
-16,943
| -58% | -$540K | ﹤0.01% | 3606 |
|
|
2013
Q2 | $894K | Buy |
+29,079
| New | +$973K | ﹤0.01% | 2984 |
|
Other funds holding MDCO
Citigroup's MDCO Position: Q1 2020 in Review
Citigroup sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,541,983 shares — an estimated $216M sold.
Citigroup first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $216M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Citigroup reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Citigroup sold 2,541,983 Medicines Co shares in Q1 2020, an estimated $216M.
- Citigroup first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Citigroup's Medicines Co position peaked at $216M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Citigroup's 13F filing for Q1 2020, filed 12 May 2020.